Financing type: non-brokered private placement
Gross proceeds: $3.5-million in cash deposited into third party escrow by an arm's-length subscriber
Offering: 14 million common shares of the company deposited into third party escrow
Offering price: 25 cents per share
Monthly release: Over a 24-month period, the cash and shares will be released from their respective escrow accounts based on the company's market price, calculated at the time of each date of release.
Warrants: Eleven million one hundred thirty thousand share purchase warrants will be issued in equal instalments to the arm's-length subscriber at the time of each monthly release. The warrants will be priced at a 5-per-cent premium to the 20-day VWAP (volume-weighted average price) and will have an expiry date of three years from the date of each warrant issuance. Upon closing, the investor has received 2.87 million warrants, exercisable at 32 cents per warrant share for a period of three years from the date of issuance.
Additional fees: The company paid the investor a corporate finance fee of $210,000 payable through the aggregate issuance of 840,000 shares deposited in third party escrow and a future aggregate issuance of 840,000 warrants. The corporate finance fee is subject to the same monthly release schedule described above.
Commissions in securities: 700,000 finders' warrants, exercisable at 32 cents per finder's warrant share, which will vest in equal monthly tranches over a period of 24 months and will have an expiry date of three years from the date of issuance (The monthly release and monthly issuance of warrants are subject to exchange acceptance.)
Disclosure: Refer to the company's news releases dated Aug. 17, 2026, and Nov. 5, 2026.
© 2026 Canjex Publishing Ltd. All rights reserved.